Prevalence of and causative factors in white-coat hypertension: Results of the Japanese Multicenter Study on Barnidipine with Ambulatory Blood Pressure Monitoring

Blood Pressure Monitoring

Volumn 6, Issue SUPPL. 2, 2001, Pages

  Saito, Ikuo ^a   Imai, Yutaka ^a   Shimada, Kazuyuki ^a   Kuwajima, Iwao ^a   Abe, Keishi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Ambulatory blood pressure monitoring; Antihypertensive therapy; Barnidipine; White coat hypertension; White coat phenomenon

Indexed keywords

ANTIHYPERTENSIVE AGENT; MEPIRODIPINE;

ADRENERGIC SYSTEM; ADULT; AGE; AGED; ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORBIDITY; MORTALITY; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SEX DIFFERENCE; WHITE COAT HYPERTENSION;

EID: 0035698990     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. White-coat hypertension: Misnomers, misconceptions and misunderstandings. What should we do next?
2. Difference between clinic and daytime blood pressure is not a measure of the white coat effect
3. Comparison of casual blood pressure and twenty-four-hour ambulatory blood pressure in high school students
4. Sympathetic nerve activity in the clinic and at home in young patients with white-coat hypertension
5. Comparison of clinic and home blood pressure levels and the role of the sympathetic nervous system in clinic-home differences
6. 'White coat' versus 'sustained' borderline hypertension in Tecumseh, Michigan
7. How common is white coat hypertension?
8. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension
9. White coat hypertension and white coat effect. Similarities and differences
10. Frequency and determinants of white coat hypertension in mild to moderate hypertension: A primary care-based study
11. How good are standardized blood pressure recordings for diagnosing hypertension? A comparison between office and ambulatory blood pressure
12. Discrepancy between screening blood pressure and ambulatory blood pressure: A community-based study in Ohasama
13. Overdiagnosis of hypertension in the elderly
14. Ambulatory blood pressure in normotensive compared with hypertensive subjects
15. Variability between current definitions of 'normal' ambulatory blood pressure. Implications in the assessment of white coat hypertension
16. Recommendations for the use of home (self) and ambulatory blood pressure monitoring
17. Reference values for self-recorded blood pressure: A meta-analysis of summary data
18. White coat effect and reactivity to stress: Cardiovascular and autonomic nervous system responses
19. Clonidine test and captopril test in young patients with white-coat hypertension
20. Serum cortisol in the white-coat phenomenon
21. Muscle and skin sympathetic nerve traffic during the 'white-coat' effect
22. 'White coat hypertension' in adolescents: Increased values of urinary cortisol and endothelin
23. Isolated office hypertension: A prehypertensive state?
24. Identification of subjects with white-coat hypertension and persistently normal ambulatory blood pressure
25. Follow-up clinic and ambulatory blood pressure in untreated white-coat hypertensive patients (evaluation after 2-5 years)
26. Home blood pressure as a predictor of future blood pressure stability in borderline hypertension. The Tecumseh study
27. Long-term changes in clinic blood pressure in patients with white-coat hypertension
28. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension
29. Cardiovascular outcome in white-coat versus sustained mild hypertension: A 10-year follow-up study
30. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
31. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
32. Serum lipids in young patients with white-coat hypertension
33. Diagnosis of mild hypertension by ambulatory blood pressure monitoring
34. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy?
35. Target organ status and serum lipids in patients with white coat hypertension
36. White-coat hypertension as a cause of cardiovascular dysfunction
37. Isolated office hypertension and end-organ damage
38. Left ventricular filling profiles in young white-coat hypertensive patients without hypertrophy
39. Definition of white-coat hypertension and serum lipids
40. Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recording
41. Characterization of antihypertensive therapy by whole-day blood pressure monitoring
42. Antihypertensive effect of isradipine administered once or twice daily on ambulatory blood pressure
43. Differential effects of doxazosin on clinic and ambulatory pressure according to age, gender, and presence of white coat hypertension. Results of the HALT study
44. The effect of antihypertensive treatment with dihydropyridine calcium antagonists on white-coat hypertension
45. Effect of manidipine and delapril on clinic and ambulatory blood pressure
46. Prognostic value of ambulatory blood pressure. Current evidence and clinical implication
47. Clinical value of ambulatory blood pressure monitoring
48. Use and interpretation of ambulatory blood pressure monitoring: Recommendations of the British Hypertension Society